Transgenic mice overexpressing aldose reductase in Schwann cells show more severe nerve conduction velocity deficit and oxidative stress under hyperglycemic stress

被引:81
作者
Song, ZT
Fu, DTW
Chan, YS
Leung, S
Chung, SSM
Chung, SK
机构
[1] Univ Hong Kong, Inst Mol Biol, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Fac Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1016/S1044-7431(03)00096-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
To further understand the role of aldose reductase (AR) in the etiology of diabetic neuropathy, we generated transgenic mice that overexpress AR specifically in the Schwann cells under the control of the rat myelin protein zero (P,) promoter. One of the transgenic mouse lines, which has overexpression of AR mRNA in the Schwann cell only and higher AR activity in the sciatic nerve, was used to examine the relationship between increased AR activity and motor nerve conduction velocity (MNCV) deficit under diabetic and galactosemic conditions. Under these conditions, nontransgenic mice showed a slight reduction in MNCV compared to those of controls. However, transgenic mice exhibited a significantly greater reduction in MNCV under these conditions, particularly under galactosemic condition, indicating that a Schwann cell-specific increase in aldose reductase activity is sufficient to produce the phenotype. Interestingly, under galactosemic condition where the difference in MNCV deficit between transgenic and nontransgenic mice was most pronounced, there was no significant difference in accumulated galactitol levels in the sciatic nerve between these mice. These results indicate that increase in AR activity leads to greater reduction of MNCV under galactosemic and diabetic conditions, but galactitol and sorbitol levels may not be good indicators of the severity of neuropathy. On the other hand, the level of reduced glutathione (GSH) in the sciatic nerve was found to be correlated with the severity of MNCV deficit under the diabetic condition. Diabetic AR transgenic mice showed significant reduction of GSH in their sciatic nerve, whereas the diabetic nontransgenic mice showed no reduction in GSH level compared to the nondiabetic control, suggesting that AR is a key contributor to oxidative stress under diabetic condition. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:638 / 647
页数:10
相关论文
共 32 条
  • [1] COEXISTENCE OF NERVE-CONDUCTION DEFICIT WITH INCREASED NA+-K+-ATPASE ACTIVITY IN GALACTOSE-FED MICE - IMPLICATIONS FOR POLYOL PATHWAY AND DIABETIC NEUROPATHY
    CALCUTT, NA
    TOMLINSON, DR
    BISWAS, S
    [J]. DIABETES, 1990, 39 (06) : 663 - 666
  • [2] STATIL-SENSITIVE POLYOL FORMATION IN NERVE OF GALACTOSE-FED MICE
    CALCUTT, NA
    WILLARS, GB
    TOMLINSON, DR
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1988, 37 (05): : 450 - 453
  • [3] Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats
    Cameron, NE
    Cotter, MA
    Basso, M
    Hohman, TC
    [J]. DIABETOLOGIA, 1997, 40 (03) : 271 - 281
  • [4] EFFECTS OF AMINOGUANIDINE ON PERIPHERAL-NERVE FUNCTION AND POLYOL PATHWAY METABOLITES IN STREPTOZOTOCIN-DIABETIC RATS
    CAMERON, NE
    COTTER, MA
    DINES, K
    LOVE, A
    [J]. DIABETOLOGIA, 1992, 35 (10) : 946 - 950
  • [5] CHUNG S, 1989, J BIOL CHEM, V264, P14775
  • [6] In situ hybridization study of myelin protein mRNA in rats with an experimental diabetic neuropathy
    Conti, AM
    Scarpini, E
    Malosio, ML
    DiGiulio, AM
    Baron, P
    Scarlato, G
    Mantegazza, P
    Gorio, A
    [J]. NEUROSCIENCE LETTERS, 1996, 207 (01) : 65 - 69
  • [7] POLYOL PATHWAY ACTIVITY AND MYOINOSITOL METABOLISM - A SUGGESTED RELATIONSHIP IN THE PATHOGENESIS OF DIABETIC NEUROPATHY
    FINEGOLD, D
    LATTIMER, SA
    NOLLE, S
    BERNSTEIN, M
    GREENE, DA
    [J]. DIABETES, 1983, 32 (11) : 988 - 992
  • [8] GABBAY KH, 1973, NEW ENGL J MED, V288, P831, DOI 10.1056/NEJM197304192881609
  • [9] Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy
    Greene, DA
    Stevens, MJ
    Obrosova, I
    Feldman, EL
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 375 (1-3) : 217 - 223
  • [10] Hohman T. C., 1997, Diabetologia, V40, pA549